Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 280 | -9,279 | -6,616 | -4,271 | -1,688 |
| Depreciation Amortization | 284 | 1,257 | 942 | 531 | 304 |
| Accounts receivable | 323 | -546 | 15 | -340 | -386 |
| Other Working Capital | 903 | -990 | 345 | -489 | -1,065 |
| Other Operating Activity | -1,602 | 2,765 | 657 | 1,181 | 1,126 |
| Operating Cash Flow | $188 | $-6,793 | $-4,657 | $-3,389 | $-1,710 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -19 | -19 | N/A | -179 |
| Purchase Sale Intangibles | N/A | 350 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 350 | 0 | 0 | 0 |
| Investing Cash Flow | $-3 | $331 | $-19 | $N/A | $-179 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 340 | 2,064 | 1,670 | 1,396 | 168 |
| Other Financing Activity | -226 | -497 | -488 | -479 | 186 |
| Financing Cash Flow | $114 | $1,567 | $1,182 | $918 | $354 |
| Beginning Cash Position | 2,676 | 7,571 | 7,571 | 7,571 | 7,571 |
| End Cash Position | 2,975 | 2,676 | 4,077 | 5,100 | 6,037 |
| Net Cash Flow | $299 | $-4,895 | $-3,494 | $-2,471 | $-1,534 |
| Free Cash Flow | |||||
| Operating Cash Flow | 188 | -6,793 | -4,657 | -3,389 | -1,710 |
| Capital Expenditure | -3 | -19 | -19 | N/A | -179 |
| Free Cash Flow | 185 | -6,812 | -4,676 | -3,389 | -1,888 |